DrugDashboards

Market view

thrombin human and fibrinogen · Patch

3 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for thrombin human and fibrinogen, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • TachoSilAug 26, 2026
    Mfr entered
    Corza Medical GmbH · thrombin human and fibrinogen
  • TachoSilAug 1, 2026
    Mfr exited
    Corza Medical GmbH · thrombin human and fibrinogen
  • TachoSilJul 22, 2026
    Mfr entered
    Corza Medical GmbH · thrombin human and fibrinogen

Same drug class

Other molecules FDA puts in Human Blood Coagulation Factor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Thrombin human and fibrinogen in shortage right now?
No. FDA does not currently list Thrombin human and fibrinogen in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Thrombin human and fibrinogen?
1 company has marketed Thrombin human and fibrinogen in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.